The cytogenetics and molecular biology of endometrial stromal sarcoma

Cytogenetic and Genome Research

Volumn 118, Issue 2-4, 2007, Pages 182-189

  Sandberg, A A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; AROMATASE INHIBITOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

CANCER INVASION; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOSIS; ENDOMETRIUM SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; JAZF1 GENE; KARYOTYPING; MITOSIS RATE; MOLECULAR BIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SUZ12 GENE; TUMOR DIFFERENTIATION; TUMOR GROWTH;

CHROMOSOME ABERRATIONS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; RECEPTORS, STEROID; SARCOMA, ENDOMETRIAL STROMAL;

EID: 36249016887     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108299     Document Type: Review

References (74)

1. Amant F, Dorfling CM, Dreyer L, Vergote I, Lindeque BG, Van Rensburg EJ: Microsatellite instability in uterine sarcomas. Int J Gynecol Cancer 11:218-223 (2001).
2. Amant F, Moerman P, Cadron I, Hagemeijer A, Vergote I, Debiec-Rychter M: Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature. Gynecol Oncol 88:459-462 (2003).
3. Amant F, Vergote I, Moerman P: The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned. Gynecol Oncol 95:412-413 (2004a).
4. Amant F, Vloeberghs V, Woestenborghs H, Debiec-Rychter M, Verbist L, et al: ERBB-2 gene overexpression and amplification in uterine sarcomas. Gynecol Oncol 95:583-587 (2004b).
5. Balleine RL, Earls PJ, Webster LR, Mote PA, deFazio A, et al: Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma. Int J Gynecol Pathol 23:138-144 (2004).
6. Bhargava R, Shia J, Hummer AJ, Thaler HT, Tornos C, Soslow RA: Distinction of endometrial stromal sarcoma from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains. Mod Pathol 18:40-47 (2005).
7. Brunisholz Y, Miller J, Scurry J, Proietto A: Endometrial stromal sarcoma resembling adenomyosis and menstrual-phase endometrium. Gynecol Oncol 95:256-259 (2004).
8. Cheung ANY, Ng WF, Chung LP, Khoo, US: Mixed low grade and high grade endometrial stromal sarcoma of uterus: differences on immunohistochemistry and chromosome in situ hybridisation. J Clin Pathol 49:604-607 (1996a).
9. Cheung ANY, Tin VPC, Ngan HYS, Chung LP, Khoo US: Interphase cytogenetic study of endometrial stromal sarcoma by chromosome in situ hybridization. Mod Pathol 9:910-918 (1996b).
10. Chu MC, Mor G, Lim C, Zheng W, Parkash V, Schwartz PE: Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 90:170-176 (2003).
11. Chu P, Arber DA: Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 113:374-382 (2000).
12. Chu PG, Arber DA, Weiss LM, Chang KL: Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: An immunohistochemical comparison of 34 cases. Mod Pathol 14:465-471 (2001).
13. Dal Cin P, Talcott J, Abrams J, Li FP, Sandberg AA: Ins(10;19) in an endometrial stromal sarcoma. Cancer Genet Cytogenet 36:1-5 (1988).
14. Dal Cin P, Van den Berghe H, Brosens I: Involvement of 6p in an endometrial polyp. Cancer Genet Cytogenet 51:279-280 (1991).
15. Dal Cin P, Sayed Aly M, De Wever I, Moerman P, Van den Berghe H: Endometrial stromal sarcoma t(7;17)(p15-21;q12-21) is a nonrandom chromosome change. Cancer Genet Cytogenet 63:43-46 (1992).
16. Evans H: Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50:2170-2182 (1982).
17. Fletcher JA, Pinkus JL, Lage JM, Morton CC, Pinkus GS: Clonal 6p21 rearrangement is restricted to the mesenchymal component of an endometrial polyp. Genes Chromosomes Cancer 5:260-263 (1992).
18. Fresia AE, Currie JL, Farrington JE, Laxman R, Griffin CA: Uterine stromal sarcoma cell line. A cytogenetic and electron microscopic study. Cancer Genet Cytogenet 60:60-66 (1992).
19. Füzesi L, Gunawan B, Braun S, Karl MC: Endometrial stromal sarcoma with clonal chromosomal aberrations and mixed phenotype. Cancer Genet Cytogenet 84:85-88 (1995).
20. Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, et al: Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol 95:632-636 (2004).
21. Gil-Benso R, López-Ginés C, Navarro S, Carda C, Llombart-Bosch A: Endometrial stromal sarcomas: immunohistochemical, electron microscopical and cytogenetic findings in two cases. Virchows Arch 434:307-314 (1999).
22. Gunawan B, Braun S, Cortés MJ, Bergmann F, Kari C, Füzesi L: Characterization of a newly established endometrial stromal sarcoma cell line. Int J Cancer 77:424-428 (1998).
23. Gunawan B, Schulten HJ, Füzesi L: Identification of a BAC clone overlappig the t(6p12.3) breakpoint in the cell line ESS-1 derived from an endometrial stromal sarcoma. Cancer Genet Cytogenet 147:84-86 (2003).
24. Halbwedl I, Ullmann R, Kremser ML, Man YG, Isadi-Moud N, et al: Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization. Gynecol Oncol 97:582-587 (2005).
25. Havel G, Dahlenfors F, Wedell B, Mark J: Similar chromosomal evolution in a uterine stromomyosarcoma and in one of two leiomyomas from the same patient. APMIS 97:143-146 (1989).
26. Hennig Y, Caselitz J, Bartnitzke S, Bullerdiek J: A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14∼21;q11.2∼21). Cancer Genet Cytogenet 98:84-86 (1997).
27. Hitchcock CL, Norris HJ: Flow cytometric analysis of endometrial stromal sarcoma. Am J Clin Pathol 97:267-271 (1992).
28. Hrynchak M, Horsman D, Salski C, Berean K, Benedet JL: Complex karyotypic alterations in an endometrial stromal sarcoma. Cancer Genet Cytogenet 77:45-49 (1994).
29. Hrzenjak A, Tippl M, Kremser ML, Strohmeier B, Guelly C, et al: Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcoma. J Pathol 204:19-27 (2004).
30. Hrzenjak A, Moinfar F, Tavassoli FA, Strohmeier B, Kremser ML, et al: JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue. J Mol Diagn 7:388-395 (2005).
31. Huang HY, Ladanyi M, Soslow RA: Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology. Evidence for genetic heterogeneity. Am J Surg Pathol 28:224-232 (2004).
32. Iliszko M, Mandahl N, Mrózek K, Denis A, Pandis N, et al: Cytogenetics of uterine sarcomas: Presentation of eight new cases and review of the literature. Gynecol Oncol 71:172-176 (1998).
33. Khalifa MA, Hansen CH, Moore JL Jr, Rusnock EJ, Lage JM: Endometrial stromal sarcoma with focal smooth muscle differentiation: recurrence after 17 years: a follow-up report with discussion of the nomenclature. Int J Gynecol Pathol 15:171-176 (1996).
34. Kir G, Cetiner H, Karateke A, Gurbuz A, Bulbul D: Utility of MIB-1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas. Int J Gynecol Cancer 15:337-342 (2005).
35. Koontz JI, Soreng AL, Nucci M, Kuo FC, Pauwels P, et al: Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA 98:6348-6353 (2001).
36. Laxman R, Currie JL, Kurman RJ, Dudzinski M, Griffin CA: Cytogenetic profile of uterine sarcomas. Cancer 71:1283-1288 (1993).
37. Leunen K, Amant F, Debiec-Rychter M, Croes R, Hagemeijer A, et al: Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation. Gynecol Oncol 91:265-271 (2003).
38. Leunen M, Breugelmans M, De Sutter P, Bourgain C, Amy JJ: Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol 95:769-771 (2004).
39. Liokumovich P, Goldberg I, Davidson B, Gotlieb WH, Zahavi T, et al: Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis. J Clin Pathol 52:198-202 (1999).
40. Liu FS, Kohler MF, Marks JR, Bast RC Jr, et al: Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Obstet Gynecol 83:118-124 (1994).
41. Loddenkemper C, Mechsner S, Foss HD, Dallenbach FE, Anagnostopoulos I, et al: Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma. Am J Surg Pathol 27:1458-1462 (2003).
42. McCluggage WG, Sumathi VP, Maxwell P: CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 39:273-278 (2001).
43. Micci F, Walter CU, Teixeira MR, Panagopoulos I, Bjerkehagen B, et al: Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1-JJAZ1 gene fusion in t(7;17). Cancer Genet Cytogenet 144:119-124 (2003).
44. Micci F, Panagopoulos I, Bjerkehagen B, Heim S: Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res 66:107-112 (2006).
45. Miettinen M: Diagnostic Soft Tissue Pathology. (Churchill Livingstone, New York 2003).
46. Moinfar F, Kremser ML, Man YG, Zatloukal K, Tavassoli FA, Denk H: Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the nontumorous normal-appearing endometrial and myometrial tissues. Gynecol Oncol 95:662-671 (2004a).
47. Moinfar F, Regitnig P, Dastranj Tabrizi A, Denk H, Tavassoli FA: Expression of androgen receptors in benign and malignant endometrial stromal neoplasms. Virchows Arch 444:410-414 (2004b).
48. Moinfar F, Gogg-Kamerer M, Sommersacher A, Regitnig P, Man YG, et al: Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1). Potential basis for a new therapeutic approach. Am J Surg Pathol 29:485-489 (2005).
49. Nasu K, Matsui N, Narahara H, Tanaka Y, Takai N, et al: MaMi, a human endometrial stromal sarcoma cell line that constitutively produces interleukin-6, interleukin-8, and monocyte chemoattractant protein 1. Arch Pathol Lab Med 122:836-841 (1998).
50. Navarro D, Cabrera JJ, León L, Chirino R, Fernández L: Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness. J Steroid Biochem Mol Biol 41:589-596 (1992).
51. Ng TL, Gown AM, Barry TS, Cheang MCU, Chan AKW, et al: Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 18:68-74 (2005).
52. Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Trope CG: The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma. Gynecol Oncol 62:254-259 (1996).
53. Norris HJ, Taylor HB: Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 19:755-766 (1966).
54. Norris HJ, Zaloudek CJ: Mesenchymal tumors of the uterus, in Blauestein A (ed): Pathology of the female genital tract, 2nd ed., pp 352-392 (Springer-Verlag, New York 1982).
55. Nucci MR, O'Connell JT, Huettner PC, Cviko A, Sun D, Quade BJ: h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 25:455-463 (2001).
56. Oliva E, Clement P, Young R: Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol 7:257-281 (2000).
57. Oliva E, Young RH, Amin MB, Clement PB: An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus. A study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 26:403-412 (2002).
58. Pauwels P, Dal Cin P, Van de Moosdijk CNF, Vrints L, Sciot R, et al: Cytogenetics revealing the diagnosis in a metastatic endometrial stromal sarcoma. Histopathology 29:84-87 (1996).
59. Popiolek D, Yee H, Levine P, Vamvakas E, Demopoulos RI: MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus. Gynecol Oncol 90:353-357 (2003).
60. Reich O, Regauer S: Aromatase expression in low-grade endometrial stromal sarcomas: an immunohistochemical study. Mod Pathol 17:104-108 (2004).
61. Reich O, Regauer S: Endometrial stromal sarcoma - observational evidence of a genetic background? Eur J Gynaecol Oncol Pathol 26:288-290 (2005).
62. Rush DS, Tan JY, Baergen RN, Soslow RA: h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 25:253-258 (2001).
63. Rushing RS, Shajahan S, Chendil D, Wilder JL, Pulliam J, et al: Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT. Gynecol Oncol 91:9-14 (2003).
64. Salvatierra A, Tarrats A, Gomez C, Sastre JM, Balaña C: A case of c-kit positive high-grade stromal endometrial sarcoma responding to Imatinib Mesylate. Gynecol Oncol 101:545-547 (2006).
65. Satoh Y, Ishikawa Y, Miyoshi T, Mukai H, Okumura S, Nakagawa K: Pulmonary metastases from a low-grade endometrial stromal sarcoma confirmed by chromosome aberration and fluorescence in situ hybridization approaches: a case of recurrence 15 years after hysterectomy. Virchows Arch 422:173-178 (2003).
66. Sonobe H, Iwata J, Furihata M, Ohtsuki Y, Taguchi T, Shimizu K: Endometrial stromal sarcoma with clonal complex chromosome abnormalities. Report of a case and review of the literature. Cancer Genet Cytogenet 112:34-37 (1999).
67. Speleman F, Dal Cin P, Van Roy N, Van Marck E, Buytaert P, et al: Is t(6;20)(p21;q13) a characteristic chromosome change in endometrial polyps? Genes Chromosomes Cancer 3:318-319 (1991).
68. Sreekantaiah C, Li FP, Weidner N, Sandberg AA: An endometrial stromal sarcoma with clonal cytogenetic abnormalities. Cancer Genet Cytogenet 55:163-166 (1991).
69. Toki T, Shimizu M, Takagi Y, Ashida T, Konishi I: CD10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol 21:41-47 (2001).
70. Wade K, Quinn MA, Hammond I, Williams K, Cauchi M: Uterine sarcoma: Steroid receptors and response of hormonal therapy. Gynecol Oncol 39:364-367 (1990).
71. Walter TA, Fan SX, Medchill MT, Berger CS, Decker HJH, Sandberg AA: Inv(12)(p11.2q13) in an endometrial polyp. Cancer Genet Cytogenet 41:99-103 (1989).
72. Yilmaz A, Rush DS, Soslow RA: Endometrial stromal sarcomas with unusual histologic features. A report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation. Am J Surg Pathol 26:1142-1150 (2002).
73. Zaloudek C, Hendrickson M: Mesenchymal tumors of the uterus, in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract, pp 561-615 (Springer-Verlag, New York 2002).
74. Zhu XQ, Shi YF, Cheng XD, Zhao CL, Wu YZ: Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma. Gynecol Oncol 92:71-79 (2004).